A groundbreaking platform technology that utilizes unnatural base pairs to generate a vast array of xenoaptamers with unique properties and applications. Our innovative approach enables the creation of synthetic oligonucleotides with unparalleled versatility, paving the way for revolutionary advance...See more
Headquarters:
Singapore
Company Type:
SME
Company size:
1-10 Employees
Year Founded:
2022 (3 years)
Address:
79 SCIENCE PARK DRIVE; #06-01/08; SINGAPORE, 118264, SG
At a glanceThe company has corporate shareholder(s) or more than 20 individual shareholders
The company has a sophisticated ownership structure and may be part of a large corporate group
LOW
spending power
